Novel p53 splice site mutations in three families with Li-Fraumeni syndrome

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• Li-Fraumeni syndrome is linked to germline mutations in the p53 tumor suppressor gene.
• Most known p53 mutations occur within the DNA binding domain, affecting protein function.
• The role of mutations outside the core DNA binding domain in Li-Fraumeni syndrome is less understood.

Purpose of the Study:

• To investigate novel germline mutations in the p53 gene in Li-Fraumeni syndrome families.
• To identify alterations in regulatory regions of the p53 gene beyond the protein-coding sequence.
• To understand the impact of these mutations on gene expression and transcript stability.

Main Methods:

• Sequence analysis of the p53 gene in Li-Fraumeni syndrome families.
• Identification of mutations in noncoding and untranslated regions, specifically splice sites.
• Analysis of precursor mRNA splicing and transcript stability in affected cells.

Main Results:

• Novel splice site mutations were identified in three Li-Fraumeni syndrome families.
• Mutations were found at splice donor sites (introns 1 and 9) and a splice acceptor site (intron 9).
• These mutations led to unstable variant transcripts and aberrant splicing at cryptic sites.

Conclusions:

• Germline mutations affecting p53 mRNA splicing can contribute to Li-Fraumeni syndrome.
• The study underscores the necessity of analyzing noncoding and untranslated regions of the p53 gene for mutations.
• Identifying these splice site alterations expands the mutational landscape associated with Li-Fraumeni syndrome.